Welcome to NeurologyLive® 's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive 's widespread coverage in ...
The FDA set a first quarter 2027 goal date for troriluzole in spinocerebellar ataxia and plans an advisory committee after a 2025 complete response letter. Clene has filed an NDA seeking accelerated ...
Sara Cuccurullo, MD, FAAPMR, and Talya Fleming, MD, FAAPMR, of Hackensack Meridian JFK Johnson Rehabilitation Institute, ...
The clinical professor of neurology and pediatrics at The Ohio State University Wexner Medical Center discussed payer step ...
Target selection in MG increasingly depends on understanding where a therapy acts within the autoimmune pathway and which ...
The professor of applied neuroimaging at the University of Edinburgh discusses how emerging genetic and vascular mechanisms are opening new therapeutic avenues beyond traditional risk factor ...
At MSToronto 2026, investigators applied machine learning to health records, retinal scans, and blood samples to flag ...
The director of the stroke program at Marcus Neuroscience Institute discussed delays in calling 911 after stroke onset, gaps ...
Changes in health care use emerged 5 to 6 years before the first clinical manifestation of MS, with shifts in encounter ...
The professor of applied neuroimaging at the University of Edinburgh discusses emerging imaging, blood-based, and functional biomarkers for tracking cerebral small vessel disease progression and ...
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions ...
This week on NeurologyLive, there are a number of hot topics that we will be post ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results